Image from Google Jackets

Antioxidants in biology and medicine : essentials, advances, and clinical applications [E-Book]

Contributor(s): Publisher: Hauppauge, N.Y. : Nova Science Publishers, c2011Description: 1 online resourceContent type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781612094663
  • 161209466X
Subject(s): NLM classification:
  • QV 325
Online resources:
Contents:
ANTIOXIDANTS IN BIOLOGY AND MEDICINE: ESSENTIALS, ADVANCES, AND CLINICAL APPLICATIONS ; ANTIOXIDANTS IN BIOLOGY AND MEDICINE: ESSENTIALS, ADVANCES, AND CLINICAL APPLICATIONS ; Contents; Preface ; SECTION I INTRODUCTION TO OXIDATIVE STRESS AND ANTIOXIDANTS ; Introduction to Oxidative Stress; Abstract ; 1. Historical Overview ; 2. Free Radicals and Reactive Oxygen and Nitrogen Species (ROS/RNS) ; 2.1. Definitions ; 2.1.1. Free Radicals ; 2.1.2. ROS/RNS ; 2.2. Sources of ROS/RNS ; 2.2.1. Endogenous Sources ; 2.2.1.1. NAD(P)H OXIDASES ; 2.2.1.2. MITOCHONDRIA.
2.2.1.3. OTHER ENDOGENOUS SOURCES 2.2.2. Exogenous Sources; 2.2.2.1. PHYSICAL AGENTS AND PARTICULATE MATTER ; 2.2.2.2. XENOBIOTICS ; 2.2.2.3. BIOLOGIC AGENTS; 2.3. Chemical Reactivity of Major Types of ROS/RNS; 2.3.1. Superoxide (O2.- ) ; 2.3.2. Hydrogen Peroxide (H2O2) ; 2.3.3. Hydroxyl Radical (. OH) ; 2.3.4. Peroxynitrite (ONOO- ) ; 2.3.5. Nitric Oxide (. NO) and Related Nitrogen Oxides ; 2.3.6. Peroxyl Radical (LOO.) and Alkoxyl Radical (LO.) ; 2.3.7. Singlet Oxygen (1O2) ; 2.3.8. Hypochlorous Acid (HOCl) ; 2.3.9. Ozone (O3) ; 2.4. Molecular Targets of ROS/RNS and Cellular Consequences.
3. Oxidative Stress and Diseases3.1. Definitions ; 3.1.1. Oxidative Stress ; 3.1.2. Other Related Terms ; 3.2. Oxidative Stress in Diseases ; 3.2.1. Different Roles of Oxidative Stress in Diseases; 3.2.2. Diseases Involving an Oxidative Stress Mechanism ; 4. Conclusion ; 5. References; Introduction to Antioxidants ; Abstract ; 1. Definition and Mode of Antioxidant Action ; 2. Classification of Antioxidants; 3. Antioxidant Gene Regulation ; 3.1. Regulation of Antioxidant Gene Expression by Nrf2 Signaling ; 3.1.1. Historical Overview ; 3.1.2. Keap1-Nrf2-ARE Signaling.
3.1.3. Nrf2-regulated Antioxidants 3.2. Nrf2-dependent Induction of Antioxidants and Protection against Oxidative Stress ; 4. Antioxidant-based Disease Intervention; 4.1. Overall Strategies of Antioxidant-based Disease Intervention ; 4.2. Animal Studies on Antioxidant-based Disease Intervention ; 4.3. Human Studies on Antioxidant-based Disease Intervention ; 5. Caveats on Antioxidants and Antioxidant-based Disease Intervention ; 5.1. Multiple Biological Activities of Antioxidants; 5.2. Genetic Manipulations of Antioxidants ; 6. Conclusion ; 7. References.
SECTION II ANTIOXIDANTS SYNTHESIZED BY CELLS Superoxide Dismutase ; Abstract ; 1. Overview ; 1.1. Definition and History ; 1.2. Basic Characteristics ; 2. Biochemistry and Molecular Regulation ; 2.1. Biochemistry ; 2.2. Molecular Regulation; 3. Role in Health and Disease; 3.1. Animal Studies ; 3.1.1. Experimental Approaches ; 3.1.2. Role in Cardiovascular Diseases ; 3.1.3. Role in Diabetes ; 3.1.4. Role in Neurological Diseases ; 3.1.5. Role in Pulmonary Diseases ; 3.1.6. Role in Hepatic and Gastrointestinal Diseases; 3.1.7. Role in Renal Diseases ; 3.1.8. Role in Skin Diseases.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Home library Class number URL Status Date due Barcode
Electronic book Stenhouse Library Link to resource Available

Includes bibliographical references and index.

Description based on print version record.

ANTIOXIDANTS IN BIOLOGY AND MEDICINE: ESSENTIALS, ADVANCES, AND CLINICAL APPLICATIONS ; ANTIOXIDANTS IN BIOLOGY AND MEDICINE: ESSENTIALS, ADVANCES, AND CLINICAL APPLICATIONS ; Contents; Preface ; SECTION I INTRODUCTION TO OXIDATIVE STRESS AND ANTIOXIDANTS ; Introduction to Oxidative Stress; Abstract ; 1. Historical Overview ; 2. Free Radicals and Reactive Oxygen and Nitrogen Species (ROS/RNS) ; 2.1. Definitions ; 2.1.1. Free Radicals ; 2.1.2. ROS/RNS ; 2.2. Sources of ROS/RNS ; 2.2.1. Endogenous Sources ; 2.2.1.1. NAD(P)H OXIDASES ; 2.2.1.2. MITOCHONDRIA.

2.2.1.3. OTHER ENDOGENOUS SOURCES 2.2.2. Exogenous Sources; 2.2.2.1. PHYSICAL AGENTS AND PARTICULATE MATTER ; 2.2.2.2. XENOBIOTICS ; 2.2.2.3. BIOLOGIC AGENTS; 2.3. Chemical Reactivity of Major Types of ROS/RNS; 2.3.1. Superoxide (O2.- ) ; 2.3.2. Hydrogen Peroxide (H2O2) ; 2.3.3. Hydroxyl Radical (. OH) ; 2.3.4. Peroxynitrite (ONOO- ) ; 2.3.5. Nitric Oxide (. NO) and Related Nitrogen Oxides ; 2.3.6. Peroxyl Radical (LOO.) and Alkoxyl Radical (LO.) ; 2.3.7. Singlet Oxygen (1O2) ; 2.3.8. Hypochlorous Acid (HOCl) ; 2.3.9. Ozone (O3) ; 2.4. Molecular Targets of ROS/RNS and Cellular Consequences.

3. Oxidative Stress and Diseases3.1. Definitions ; 3.1.1. Oxidative Stress ; 3.1.2. Other Related Terms ; 3.2. Oxidative Stress in Diseases ; 3.2.1. Different Roles of Oxidative Stress in Diseases; 3.2.2. Diseases Involving an Oxidative Stress Mechanism ; 4. Conclusion ; 5. References; Introduction to Antioxidants ; Abstract ; 1. Definition and Mode of Antioxidant Action ; 2. Classification of Antioxidants; 3. Antioxidant Gene Regulation ; 3.1. Regulation of Antioxidant Gene Expression by Nrf2 Signaling ; 3.1.1. Historical Overview ; 3.1.2. Keap1-Nrf2-ARE Signaling.

3.1.3. Nrf2-regulated Antioxidants 3.2. Nrf2-dependent Induction of Antioxidants and Protection against Oxidative Stress ; 4. Antioxidant-based Disease Intervention; 4.1. Overall Strategies of Antioxidant-based Disease Intervention ; 4.2. Animal Studies on Antioxidant-based Disease Intervention ; 4.3. Human Studies on Antioxidant-based Disease Intervention ; 5. Caveats on Antioxidants and Antioxidant-based Disease Intervention ; 5.1. Multiple Biological Activities of Antioxidants; 5.2. Genetic Manipulations of Antioxidants ; 6. Conclusion ; 7. References.

SECTION II ANTIOXIDANTS SYNTHESIZED BY CELLS Superoxide Dismutase ; Abstract ; 1. Overview ; 1.1. Definition and History ; 1.2. Basic Characteristics ; 2. Biochemistry and Molecular Regulation ; 2.1. Biochemistry ; 2.2. Molecular Regulation; 3. Role in Health and Disease; 3.1. Animal Studies ; 3.1.1. Experimental Approaches ; 3.1.2. Role in Cardiovascular Diseases ; 3.1.3. Role in Diabetes ; 3.1.4. Role in Neurological Diseases ; 3.1.5. Role in Pulmonary Diseases ; 3.1.6. Role in Hepatic and Gastrointestinal Diseases; 3.1.7. Role in Renal Diseases ; 3.1.8. Role in Skin Diseases.

Master record variable field(s) change: 050, 082

There are no comments on this title.

to post a comment.
London Health Libraries Koha Consortium privacy notice